Page last updated: 2024-12-07

eth 1001

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ETH 1001: Ca++ carrier; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14009349
SCHEMBL ID678280
MeSH IDM0132916

Synonyms (17)

Synonym
eth 1001
58801-34-6
calcium ionophore
calcium ionophore i
AKOS015896894
SCHEMBL678280
CA-1001 ,
calcium ionophore i, selectophore(tm), function tested, >=99.0%
calcium-ionophore i
(17r,18r)-diethyl 13,17,18,22-tetramethyl-14,21-dioxo-16,19-dioxa-13,22-diazatetratriacontane-1,34-dioate
D96064
AS-56050
5-(4-ethoxy-phenyl)-2h-pyrazole-3-carboxylicacid
EX-A6685
CS-0129640
HY-136460
diethyl (17r,18r)-13,17,18,22-tetramethyl-14,21-dioxo-16,19-dioxa-13,22-diazatetratriacontanedioate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]